GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds

$583,253
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2019 · CA

North American Pancreatitis Study 2 (NAPS2)

$583,185
University Of Pittsburgh At Pittsburgh · R01 · FY2005 · DK

Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq

$583,099
Nancy L Allbritton · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA

TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer

$583,071
Gerardo Guillermo Mackenzie · University Of California At Davis · R01 · FY2023 · CA

Common and rare sequence variants in breast cancer risk

$583,065
Sean Vahram Tavtigian · University Of Utah · R01 · FY2021 · CA

Deployable Ultrasound Applicators for MRI Guided Thermal Therapy of Pancreatic Cancer

$582,871
Chris John Diederich · University Of California, San Francisco · R01 · FY2020 · EB

DESIGNING NOVEL STRATEGIES TO TARGET TUMOR-PROMOTING FUNCTIONS OF PANCREATIC CANCER FIBROBLAST SUBTYPES

$582,839
Whitehead Institute For Biomedical Research · · FY2022 · Defense Health Agency

Genomic and genetic studies of endocrine cancers

$582,719
Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer

$582,311
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2025 · CA

Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response

$582,111
Theodore S Lawrence · University Of Michigan At Ann Arbor · U01 · FY2021 · CA

Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response

$582,111
Theodore S Lawrence · University Of Michigan At Ann Arbor · U01 · FY2020 · CA

Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer

$581,935
Michael F Tweedle · Ohio State University · R01 · FY2016 · EB

Pancreas Cancer Biospecimens Repository

$581,812
Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2008 · CA

Role of Neurotrophins in the Development of the Mammalian Nervous System

$581,426
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Targeting Stromal Influences on BCKA Addiction in PDAC Tumors

$581,396
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

Sensitization to Chemoradiation by Therapeutic Targeting of the DNA Damage Response

$581,178
Theodore S Lawrence · University Of Michigan At Ann Arbor · U01 · FY2018 · CA

Genetically-engineered Bacteria Overcome Therapy Resistance

$581,087
Ralph R Weichselbaum · University Of Chicago · R01 · FY2024 · CA

Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial

$581,039
Lei Zheng · Johns Hopkins University · R01 · FY2021 · CA

Alcohol Reduction in Medical Illnesses:HCV as Prototype

$580,975
Case Western Reserve University · R01 · FY2003 · AA

Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma

$580,946
Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA

Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

$580,914
Farrokh Dehdashti · Washington University · R01 · FY2020 · CA

Structure-informed dissection of cancer-specific intracellular and paracrine networks

$580,864
Barry H Honig · Columbia University Health Sciences · U54 · FY2023 · CA

Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities

$580,586
Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2024 · CA

Serum Proteomic Biomarkers for Colon & Pancreatic Cancer

$580,556
William L Bigbee · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · CA

Novel Determinants and Measures of Smokeless Tobacco Use

$580,454
Dorothy K Hatsukami · University Of Minnesota · R01 · FY2009 · CA